Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
Tempus AI, Inc.
organization8 mentionslast seen Oct 27, 2026
Company with a library of multimodal data that entered into licensing agreements with Recursion.
Relationships 15
- Tempus AI, Inc.acquiresPersonalis, Inc.99% confidence2 sources
- Tempus AI, Inc.employsEric Lefkofsky97% confidence1 source
- Tempus AI, Inc.employsRyan Fukushima96% confidence1 source
- Tempus AI, Inc.funded byNeuro Order Form93% confidence1 source
- Tempus AI, Inc.funded byOnco Statement of Work93% confidence1 source
- Tempus AI, Inc.suppliesPathos AI, Inc.93% confidence1 source
- Tempus AI, Inc.suppliesBristol Myers Squibb93% confidence1 source
- Recursion Pharmaceuticals, Inc.partners withTempus AI, Inc.92% confidence1 source
- Tempus AI, Inc.developsagentic tool92% confidence1 source
- Tempus AI, Inc.developsLawVu Lens92% confidence1 source
- Tempus AI, Inc.suppliesRecursion Pharmaceuticals, Inc.91% confidence1 source
- Tempus AI, Inc.commercializesde-identified multimodal real-world data90% confidence1 source
- Recursion Pharmaceuticals, Inc.suppliesTempus AI, Inc.90% confidence1 source
- Tempus AI, Inc.suppliesPersonalis, Inc.90% confidence1 source
- Tempus AI, Inc.acquiresPersonalis, Inc.90% confidence1 source
Relationship
Tempus AI, Inc.acquiresPersonalis, Inc.
99% confidence2 supporting mentionsfrom Jul 20, 2026
Either name opens that entity’s relationships.
Sources 2
- newsPR NewswireOct 27, 2026PSNL Investor Investigation: Personalis Shareholders Are Alerted to the Pending Investigation into the $16.25 per Share Merger
Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc. in a merger in which Tempus AI is taking the company private for $16.25 per share
- filingSEC EDGAROct 6, 2026Personalis, Inc. 8-K: Item 8.01: Other Events
Personalis, Inc., entered into an Agreement and Plan of Merger with Tempus AI, Inc.